Clinical Services
Total Trials
18
As Lead Sponsor
11
As Collaborator
7
Total Enrollment
3,625
NCT01699438
Mesalazine Treatment in IBS (The MIBS Study)
Phase: Phase 2
Role: Collaborator
Start: Apr 30, 2012
Completion: Feb 28, 2017
NCT01716039
Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)
Role: Lead Sponsor
Start: Jun 30, 2013
Completion: Jul 18, 2016
NCT01698307
Enhanced Algorithm for Crohn's Treatment Incorporating Early Combination Therapy
Phase: Phase 4
Start: Mar 28, 2014
Completion: Apr 16, 2020
NCT03261206
Stopping Aminosalicylate Therapy in Inactive Crohn's Disease
Start: Nov 20, 2017
Completion: Jun 30, 2026
NCT03765450
Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis
Phase: N/A
Start: Dec 21, 2018
Completion: Mar 2, 2026
NCT04259138
Determination of the Optimal Treatment Target in Ulcerative Colitis
Start: Feb 18, 2020
Completion: Mar 31, 2026
NCT04576000
Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis
Start: Aug 25, 2020
Completion: Dec 2, 2021
NCT04590989
Empowering Consumers to 'PREVENT' Diet-related Diseases Through 'OMICS' Sciences
Start: Oct 26, 2020
Completion: Jun 14, 2021
NCT04847739
Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)
Start: Sep 13, 2021
Completion: Aug 31, 2026
NCT05252273
Assessment of Patients With Acute Pouchitis Treated With Antibiotics
Start: Dec 7, 2021
Completion: Dec 9, 2024
NCT05542355
EXL01 in the Maintenance of Steroid-induced Clinical Response/Remission in Participants With Mild to Moderate Crohn's Disease
Phase: Phase 1
Start: Mar 20, 2023
Completion: Oct 2, 2024
NCT05928039
PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease
Start: Oct 25, 2023
Completion: Dec 31, 2028
NCT06249555
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study
Start: Mar 20, 2024
Completion: Dec 31, 2026
NCT06363383
A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants
Start: May 9, 2024
Completion: Jul 4, 2025
NCT06670638
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
Start: Jun 19, 2024
Completion: Nov 30, 2026
NCT06257706
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Start: Aug 7, 2024
Completion: Sep 6, 2028
NCT06997965
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
Start: Oct 1, 2025
Completion: Apr 1, 2028
Loading map...